Search Results - "Irina Panovska Stavridis"
-
1
Interplay between lymphocyte subpopulation, inflammatory cytokines and their correlation with oxidative stress parameters in COVID-19
Published in Italian journal of medicine (01-01-2022)“…Our objective was to investigate the inflammatory and oxidative stress markers in patients with moderate and severe form of COVID-19. In addition, we show the…”
Get full text
Journal Article -
2
P1686: LONG‐TERM COMORBIDITY AND HEALTH PROBLEMS IN ACUTE MYELOID LEUKEMIA (AML) SURVIVORS: AN INTERNATIONAL AML SURVIVORSHIP STUDY
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
3
-
4
Early-Onset Colorectal Cancer in a Young Woman with Type 1 Gaucher Disease
Published in European journal of case reports in internal medicine (15-06-2022)“…Introduction: Gaucher disease (GD) is a rare inherited lysosomal storage disease characterized by multi-system impairment. One of its main features is the…”
Get full text
Journal Article -
5
Gaucher disease in North Macedonia: Unexpected prevalence of the N370S GBA1 allele with attenuated disease expression
Published in Molecular genetics and metabolism reports (01-09-2022)“…The majority of Gaucher Disease (GD) cases result from pathologic mutations in the GBA1 gene. A rich mutational spectrum of about 500 identified variants has…”
Get full text
Journal Article -
6
Current regulatory approaches for accessing potential COVID-19 therapies
Published in Journal of pharmaceutical policy and practice (16-05-2020)“…This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label…”
Get full text
Journal Article -
7
-
8
Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience
Published in Hematology, Transfusion and Cell Therapy (01-10-2022)“…Objective: Autoimmune cytopenia's, particularly autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP), complicate up to 25% of chronic…”
Get full text
Journal Article -
9
The use of remdesivir outside of clinical trials during the COVID-19 pandemic
Published in Journal of pharmaceutical policy and practice (21-09-2020)“…With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the…”
Get full text
Journal Article -
10
-
11
-
12
-
13
Prevalence of Allelic Variants and Clonality of IGHV1-69 Expressing B-Cells in Patients with Different Severity of COVID 19 Disease
Published in Blood (23-11-2021)“…Introduction: Since the first months of the COVID-19 pandemic, efforts have been made to understand the importance of broadly neutralising natural antibodies…”
Get full text
Journal Article -
14
AML-042 Epidemiology, Early Mortality, and Overall Survival in Acute Promyelocytic Leukemia: A Single Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…Acute Promyelocytic Leukemia (APL) is a subtype of acute myeloid leukemia (AML) with distinct cytogenetics, clinical, and biological characteristics. For a…”
Get full text
Journal Article -
15
Long-Term Efficacy of Treatment in Elderly Patients With Hodgkin Lymphoma: A Retrospective Analysis
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)Get full text
Journal Article -
16
HL-210 Long-Term Efficacy of Treatment in Elderly Patients With Hodgkin Lymphoma: A Retrospective Analysis
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…Hodgkin's lymphoma is a relatively rare malignancy. It can occur at any age but is commonly diagnosed in young adults aged 15 to 35, as well as in older adults…”
Get full text
Journal Article -
17
Lifestyle Behaviors and Health-Related Quality of Life in Long-Term Survivors of Acute Myeloid Leukemia: An International Survivorship Study By the Gimema, EORTC Quality of Life and Leukemia Groups
Published in Blood (02-11-2023)“…Background Major advances have been made in the treatment of acute myeloid leukemia (AML), and the number of survivors is expected to rise over the coming…”
Get full text
Journal Article Web Resource -
18
MM-254: Autologous Hematopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma as a Standard Therapeutic Procedure. Is it Feasible? Single Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)“…Autologous peripheral blood stem cell transplant (PBSCT) ideally should be performed in every myeloma patient, but in the elderly, the procedure might be risky…”
Get full text
Journal Article -
19
ABCL-337: High-Dose Chemotherapy Regimens in Therapy of NHL DLBCL: A Single-Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)“…Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR DLBCL), which accounts for approximately one-third of patients with DLBCL, remains a major cause of…”
Get full text
Journal Article -
20